J. Safra Sarasin Holding AG Reduces Stock Holdings in Xylem Inc. (NYSE:XYL)

J. Safra Sarasin Holding AG lowered its stake in shares of Xylem Inc. (NYSE:XYL) by 0.2% during the first quarter, Holdings Channel reports. The firm owned 120,322 shares of the industrial products company’s stock after selling 251 shares during the period. J. Safra Sarasin Holding AG’s holdings in Xylem were worth $14,374,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Bank of Nova Scotia grew its position in shares of Xylem by 224.9% in the 1st quarter. Bank of Nova Scotia now owns 105,366 shares of the industrial products company’s stock valued at $12,587,000 after buying an additional 72,940 shares during the last quarter. Pathway Financial Advisers LLC boosted its stake in Xylem by 1,690.6% in the first quarter. Pathway Financial Advisers LLC now owns 5,694 shares of the industrial products company’s stock valued at $680,000 after acquiring an additional 5,376 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd boosted its stake in Xylem by 8.0% in the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 224,930 shares of the industrial products company’s stock valued at $26,869,000 after acquiring an additional 16,693 shares in the last quarter. Jupiter Asset Management Ltd. grew its holdings in shares of Xylem by 0.6% during the first quarter. Jupiter Asset Management Ltd. now owns 215,648 shares of the industrial products company’s stock worth $25,761,000 after purchasing an additional 1,374 shares during the last quarter. Finally, IFG Advisory LLC increased its position in shares of Xylem by 4.5% during the first quarter. IFG Advisory LLC now owns 22,923 shares of the industrial products company’s stock worth $2,738,000 after purchasing an additional 989 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 1.8%

NYSE:XYL opened at $142.04 on Friday. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $144.83. The company has a current ratio of 1.90, a quick ratio of 1.41 and a debt-to-equity ratio of 0.17. The stock’s 50 day simple moving average is $129.44 and its 200-day simple moving average is $124.29. The firm has a market cap of $34.57 billion, a P/E ratio of 36.89, a PEG ratio of 2.63 and a beta of 1.11.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.15 by $0.11. The firm had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. Xylem’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period last year, the firm posted $1.09 EPS. Equities analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 26th. Investors of record on Thursday, May 29th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, May 29th. Xylem’s dividend payout ratio is currently 43.01%.

Analysts Set New Price Targets

XYL has been the subject of a number of research analyst reports. Raymond James Financial raised Xylem to a “hold” rating in a research report on Thursday, May 15th. Robert W. Baird reduced their price objective on Xylem from $149.00 to $146.00 and set an “outperform” rating for the company in a research note on Wednesday, April 30th. Royal Bank Of Canada raised their target price on shares of Xylem from $143.00 to $147.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 30th. Citigroup reaffirmed a “buy” rating and issued a $152.00 target price (up from $137.00) on shares of Xylem in a report on Monday, July 14th. Finally, JPMorgan Chase & Co. started coverage on shares of Xylem in a research note on Friday, May 30th. They set an “overweight” rating and a $148.00 price target for the company. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and an average price target of $151.14.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.